Pasithea Therapeutics Corp. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pasithea Therapeutics Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2022 to Q1 2024.
  • Pasithea Therapeutics Corp. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $32K, a 93% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $32K -$429K -93% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $79.3K -$421K -84.2% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $378K -$554K -59.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $420K +$9.49K +2.31% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $461K Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $500K Dec 31, 2022 10-K 2024-03-29
Q3 2022 $932K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $410K Jun 30, 2022 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.